As of May 22
| +0.18 / +5.01%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 13.50, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +258.09% increase from the last price of 3.77.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.